A detailed history of Ieq Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ieq Capital, LLC holds 110,939 shares of ABT stock, worth $13 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
110,939
Previous 108,990 1.79%
Holding current value
$13 Million
Previous $11.3 Million 11.68%
% of portfolio
0.16%
Previous 0.15%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $195,036 - $230,235
1,949 Added 1.79%
110,939 $12.6 Million
Q2 2024

Aug 12, 2024

BUY
$100.73 - $112.44 $216,972 - $242,195
2,154 Added 2.02%
108,990 $11.3 Million
Q1 2024

May 08, 2024

BUY
$109.52 - $120.96 $1.51 Million - $1.67 Million
13,805 Added 14.84%
106,836 $12.1 Million
Q4 2023

Feb 07, 2024

SELL
$90.19 - $110.4 $74,857 - $91,632
-830 Reduced 0.88%
93,031 $10.2 Million
Q3 2023

Nov 03, 2023

SELL
$95.53 - $114.62 $412,880 - $495,387
-4,322 Reduced 4.4%
93,861 $9.09 Million
Q2 2023

Aug 07, 2023

BUY
$100.78 - $112.29 $516,094 - $575,037
5,121 Added 5.5%
98,183 $10.7 Million
Q1 2023

May 01, 2023

BUY
$96.86 - $114.01 $537,185 - $632,299
5,546 Added 6.34%
93,062 $9.42 Million
Q4 2022

Feb 03, 2023

BUY
$95.06 - $111.52 $1.34 Million - $1.57 Million
14,096 Added 19.2%
87,516 $9.61 Million
Q3 2022

Nov 03, 2022

SELL
$96.76 - $112.03 $1.29 Million - $1.49 Million
-13,334 Reduced 15.37%
73,420 $7.1 Million
Q2 2022

Jul 27, 2022

SELL
$102.07 - $123.37 $291,818 - $352,714
-2,859 Reduced 3.19%
86,754 $9.43 Million
Q1 2022

Apr 26, 2022

BUY
$114.02 - $139.04 $707,266 - $862,465
6,203 Added 7.44%
89,613 $10.6 Million
Q4 2021

Jan 31, 2022

BUY
$115.53 - $141.46 $319,324 - $390,995
2,764 Added 3.43%
83,410 $11.7 Million
Q3 2021

Nov 09, 2021

BUY
$116.66 - $129.06 $1.89 Million - $2.09 Million
16,161 Added 25.06%
80,646 $9.53 Million
Q2 2021

Jul 29, 2021

SELL
$105.79 - $124.53 $1 Million - $1.18 Million
-9,454 Reduced 12.79%
64,485 $7.48 Million
Q1 2021

May 04, 2021

BUY
$108.84 - $128.23 $551,383 - $649,613
5,066 Added 7.36%
73,939 $8.86 Million
Q4 2020

Feb 03, 2021

SELL
$105.0 - $114.42 $140,805 - $153,437
-1,341 Reduced 1.91%
68,873 $7.54 Million
Q3 2020

Nov 03, 2020

SELL
$91.64 - $111.29 $549,015 - $666,738
-5,991 Reduced 7.86%
70,214 $7.64 Million
Q2 2020

Jul 31, 2020

BUY
$76.57 - $98.0 $3.38 Million - $4.33 Million
44,159 Added 137.8%
76,205 $6.97 Million
Q1 2020

May 07, 2020

BUY
$62.82 - $91.86 $532,273 - $778,329
8,473 Added 35.94%
32,046 $2.53 Million
Q4 2019

Feb 11, 2020

SELL
$78.51 - $87.4 $3.43 Million - $3.82 Million
-43,710 Reduced 64.96%
23,573 $2.05 Million
Q4 2019

Feb 04, 2020

BUY
$78.51 - $87.4 $5.28 Million - $5.88 Million
67,283 New
67,283 $594,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ieq Capital, LLC Portfolio

Follow Ieq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.